GRAIL: Buy Τhe Test That Could Redefine Cancer Screening

Below we will discuss about a company that started as a biotech startup that had the vision of detecting cancer early but now is evolving into a clinically validated enterpriseMr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on risk management, which is accompanied by in-depth financial market analysis (fundamental, macro and technical) to control the risk undertaken by the portfolios. He invests in all financial instruments globally (stocks, ...